Johan Larsson retweeted
Really happy to share that our research paper looking at immigrants vs. native Danish patients treated for HFrEF within the public Danish Health Care system is published in JACC HF - jacc.org/doi/10.1016/j.jchf.…
Johan Larsson retweeted
Pleural Effusion and Invasive Hemodynamic Measurements in Advanced Heart Failure @signeglargaard @BFHcardio @soerenlk #AHAJournals ahajrnls.org/4fgYmnz
Happy to share our latest publication in the @ESCHeartFailure journal!
Is socioeconomic deprivation linked to impaired hemodynamics at evaluation for advanced HF due to barriers in the referral system?
Find out!
doi.org/10.1002/ehf2.15089
@RigsHeart
6
168
Johan Larsson retweeted
It's well known that lower income people tend to suffer much worse health. Is poverty at the heart of this disparity, and, if so, could a large cash transfer help close this gap? We examine an RCT that provided 1000 low income participants $1000/month for 3 years. We find…
Johan Larsson retweeted
Patients with lower levels of education may be disfavored for HTx/LVADs according to data from 629 patients evaluated for advanced HF in Copenhagen! #advancedHF @_JohanLarsson @SLKristensen @FinnGustafsson
🔗: jhltonline.org/article/S1053…
Three great days of Heart Failure discussions with our Scottish colleagues from Glasgow. Huge thanks to @DCAcademyDK and the organizers from both countries.
Johan Larsson retweeted
Compared with no invitation for routine PSA testing, a single invitation for a PSA screening test reduced prostate cancer mortality at a median follow-up of 15 years, but the absolute mortality benefit was small.
ja.ma/43J43q3
#EAU24
Important insights from nearly 20 years of advanced HF therapy allocation. We need to ensure that patients are offered life-saving treatments on an equal basis.
Read our latest publication in @TheJHLT
doi.org/10.1016/j.healun.202…
#HealthEquity
#heartfailure
Patients with a lower level of education might be disfavored for advanced HF therapies and could require specific attention in the advanced HF care center.
Great work by @_JohanLarsson
Influence of socioeconomic status on rates of advanced heart failure therapies
Johan Larsson retweeted
Clinical PhD-fellowship now available for ambitious MD within the field of #coronary disease and #overweight/#obesity. Involves randomized trial with intravascular imaging. Collaboration btw @HGHHjerte and @Stenodiabetes.
See post below. Please share.
linkedin.com/posts/christine…
Johan Larsson retweeted
Early is Better Than Late, but Late is Better Than Never: Referral to Advanced Heart Failure Cardiology #heartfailure #LVAD
cvia-journal.org/early-is-be…
MILESTONE REACHED ✅
The 100th patient was included today in the Screening for advanced heart failure in stable outpatients (SAINTS) study!!!
🎉🎉
clinicaltrials.gov/study/NCT…
@FinnGustafsson @SLKristensen @BHansen_MD @RigsHeart
Johan Larsson retweeted
My thoughts on the CASTLE-HTx trial of #afib ablation vs medical therapy in #heartfailure medscape.com/viewarticle/995… #ESCCongress – at Lincolnshire, KY
Johan Larsson retweeted
Prof. @FinnGustafsson at #ESCcongress “How-To Symposium” on advanced HF treatment:
🫀The importance of maximal oxygen uptake and right heart catheterization in the timing for listing
🫀One refers not to #HTX but to the assessment of HTX, #LVAD, or palliation
🫀Refer early‼️
9 years and +2 kids later it was time to participate again in #christiansborgrundt 2023 🏊♂️ Not 31 minutes this time but very happy with 2 km in 34:39 🙂
1
13
307
Johan Larsson retweeted
Fantastisk præsentation af @NajaVinding til Young Investigators Award! 🏆Udgivet simultant i @CircAHA 👏🏻
Studiet viste en ⬆️ femårig forekomst af #stroke og ☠️ efter TIA 🧠
Resultaterne viser at langvarig antitromboptisk behandling og opfølgning er nøglen? 🔑🩸
Johan Larsson retweeted
Very happy 👇finally published - hard work done by skilled PhD student @_JohanLarsson - eager to hear any comments re. findings, while we wait for the results of the ongoing 🇩🇰 cluster-RCT comp spiro and eplererenone classic.clinicaltrials.gov/c… @RigsHeart
In a nationwide 🇩🇰 cohort of #HFrEF patients who initiated MRA, there was no difference in outcomes with #eplerenone vs #spironolactone. Treatment was more often withdrawn with spironolactone ⤵️
academic.oup.com/ehjcvp/adva…
#EHJPharmacotherapy 💊
@AgewallStefan @ESC_Journals































